Predictors of poor outcome despite recanalization: A multiple regression analysis of the NASA registry

Journal of NeuroInterventional Surgery

Volumn 8, Issue 3, 2016, Pages 224-229

  Linfante, Italo ^a,b   Starosciak, Amy K ^b,c   Walker, Gail R ^c   Dabus, Guilherme ^a,b   Castonguay, Alicia C ^d   Gupta, Rishi ^e   Sun, Chung Huan J ^e   Martin, Coleman ^f   Holloway, William E ^f   Mueller Kronast, Nils ^g   English, Joey D ^h   Malisch, Tim W ⁱ   Marden, Franklin A ⁱ   Bozorgchami, Hormozd ^j   Xavier, Andrew ^k   Rai, Ansaar T ^l   Froehler, Michael T ^m   Badruddin, Aamir ⁿ   Nguyen, Thanh N ^o   Taqi, M Asif ^f,p   Abraham, Michael G ^q   Janardhan, Vallabh ^r   Shaltoni, Hashem ^s   Novakovic, Roberta ^t   Yoo, Albert J ^u   Abou Chebl, Alex ^v   Chen, Peng R ^w   Britz, Gavin W ^x   Kaushal, Ritesh ^y   Nanda, Ashish ^z   Issa, Mohammad A ^d   Nogueira, Raul G ^e   Zaidat, Osama O ^d   more..

^a BAPTIST CARDIAC AND VASCULAR INSTITUTE   (United States)

^b BAPTIST HOSPITAL OF MIAMI   (United States)

^c MIAMI CANCER INSTITUTE   (United States)

^d FROEDTERT MEMORIAL LUTHERAN HOSPITAL   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f St Luke's Kansas City   (United States)

^g Delray Medical Center   (United States)

^h CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

ⁱ ALEXIAN BROTHERS MEDICAL CENTER   (United States)

^j OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^k WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l WEST VIRGINIA UNIVERSITY HOSPITALS   (United States)

^m VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

ⁿ Provena St Joseph Medical Center   (United States)

^o BOSTON MEDICAL CENTER   (United States)

^p DESERT REGIONAL MEDICAL CENTER   (United States)

^q UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^r Texas Stroke Institute   (United States)

^s BAYLOR COLLEGE OF MEDICINE   (United States)

^t UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^u MASSACHUSETTS GENERAL HOSPITAL   (United States)

^v Baptist Health Louisville   (United States)

^w UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^x HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^y SAINT LOUIS UNIVERSITY   (United States)

^z UNIVERSITY OF MISSOURI   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BASILAR ARTERY OBSTRUCTION; CEREBROVASCULAR ACCIDENT; DIABETES MELLITUS; FEMALE; HUMAN; INTERNAL CAROTID ARTERY OCCLUSION; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE; MEDICAL HISTORY; MULTIPLE REGRESSION; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANKIN SCALE; RECANALIZATION; REGISTER; SOLITAIRE FLOW RESTORATION DEVICE; VERY ELDERLY; CLINICAL TRIAL; DEVICES; MIDDLE AGED; MULTICENTER STUDY; NORTH AMERICA; PREDICTIVE VALUE; PROCEDURES; REGRESSION ANALYSIS; REPERFUSION; RISK FACTOR; STENT; STROKE; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; NORTH AMERICA; PREDICTIVE VALUE OF TESTS; REGISTRIES; REGRESSION ANALYSIS; REPERFUSION; RISK FACTORS; STENTS; STROKE; TREATMENT OUTCOME;

EID: 84958659536     PISSN: 17598478     EISSN: 17598486     Source Type: Journal    
DOI: 10.1136/neurintsurg-2014-011525     Document Type: Article

References (31)

1. Nogueira RG, Liebeskind DS, Sung G, et al. Predictors of good clinical outcomes, mortality, and successful revascularization in patients with acute ischemic stroke undergoing thrombectomy: pooled analysis of the Mechanical Embolus Removal in Cerebral Ischemia (MERCI) and Multi MERCI Trials. Stroke 2009;40:3777-83.
2. Smith WS. Safety of mechanical thrombectomy and intravenous tissue plasminogen activator in acute ischemic stroke. Results of the multi Mechanical Embolus Removal in Cerebral Ischemia (MERCI) trial, part I. AJNR Am J Neuroradiol 2006;27:1177-82.
3. Nogueira RG, Smith WS. Safety and efficacy of endovascular thrombectomy in patients with abnormal hemostasis: pooled analysis of the MERCI and multi MERCI trials. Stroke 2009;40:516-22.
4. Smith WS, Sung G, Saver J, et al. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 2008;39:1205-12.
5. Saver JL, Jahan R, Levy EI, et al. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet 2012;380:1241-9.
6. Nogueira RG, Lutsep HL, Gupta R, et al. Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet 2012;380:1231-40.
7. Zaidat OO, Castonguay AC, Gupta R, et al. North American Solitaire Stent Retriever Acute Stroke registry: post-marketing revascularization and clinical outcome results. J Neurointerv Surg 2014;6:584-8.
8. No authors listed]. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995;333:1581-7.
9. Rha JH, Saver JL. The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke 2007;38:967-73.
10. Wechsler LR, Roberts R, Furlan AJ, et al. Factors influencing outcome and treatment effect in PROACT II. Stroke 2003;34:1224-9.
11. Singer OC, Haring HP, Trenkler J, et al. Age dependency of successful recanalization in anterior circulation stroke: the ENDOSTROKE study. Cerebrovasc Dis 2013;36:437-45.
12. Ribo M, Flores A, Mansilla E, et al. Age-adjusted infarct volume threshold for good outcome after endovascular treatment. J Neurointerv Surg 2014;6:418-22.
13. Yoo AJ, Chaudhry ZA, Nogueira RG, et al. Infarct volume is a pivotal biomarker after intra-arterial stroke therapy. Stroke 2012;43:1323-30.
14. Saposnik G, Cote R, Phillips S, et al. Stroke outcome in those over 80: A multicenter cohort study across Canada. Stroke 2008;39:2310-17.
15. Kaplan RC, Tirschwell DL, Longstreth WT Jr, et al. Vascular events, mortality, and preventive therapy following ischemic stroke in the elderly. Neurology 2005;65:835-42.
16. Hussein HM, Georgiadis AL, Vazquez G, et al. Occurrence and predictors of futile recanalization following endovascular treatment among patients with acute ischemic stroke: a multicenter study. AJNR Am J Neuroradiol 2010;31:454-8.
17. Sarraj A, Albright K, Barreto AD, et al. Optimizing prediction scores for poor outcome after intra-arterial therapy in anterior circulation acute ischemic stroke. Stroke 2013;44:3324-30.
18. Flint AC, Xiang B, Gupta R, et al. THRIVE score predicts outcomes with a third-generation endovascular stroke treatment device in the TREVO-2 trial. Stroke 2013;44:3370-5.
19. Ciccone A, Valvassori L, Nichelatti M, et al. Endovascular treatment for acute ischemic stroke. New Engl J Med 2013;368:904-13.
20. Broderick JP, Palesch YY, Demchuk AM, et al. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. New Engl J Med 2013;368:893-903.
21. Nogueira RG, Yoo AJ, Buonanno FS, et al. Endovascular approaches to acute stroke, Part 2: A comprehensive review of studies and trials. AJNR. Am J Neuroradiol 2009;30:859-75.
22. Kwak HS, Hwang SB, Jin GY, et al. Predictors of functional outcome after emergency carotid artery stenting and intra-arterial thrombolysis for treatment of acute stroke associated with obstruction of the proximal internal carotid artery and tandem downstream occlusion. AJNR Am J Neuroradiol 2013;34:841-6.
23. Wolpert SM, Bruckmann H, Greenlee R, et al. Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. The rt-PA Acute Stroke Study Group. AJNR Am J Neuroradiol 1993;14:3-13.
24. Linfante I, Llinas RH, Selim M, et al. Clinical and vascular outcome in internal carotid artery versus middle cerebral artery occlusions after intravenous tissue plasminogen activator. Stroke 2002;33:2066-71.
25. Zaidat OO, Suarez JI, Santillan C, et al. Response to intra-arterial and combined intravenous and intra-arterial thrombolytic therapy in patients with distal internal carotid artery occlusion. Stroke 2002;33:1821-6.
26. Saver JL. Time is brain-quantified. Stroke 2006;37:263.
27. Wardlaw JM, Murray V, Berge E, et al. Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis. Lancet 2012;379:2364-72.
28. Saver JL, Fonarow GC, Smith EE, et al. Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke. JAMA 2013;309:2480-8.
29. Pereira VM, Gralla J, Davalos A, et al. Prospective, multicenter, single-arm study of mechanical thrombectomy using Solitaire flow restoration in acute ischemic stroke. Stroke 2013;44:2802-7.
30. Shi ZS, Liebeskind DS, Xiang B, et al. Predictors of functional dependence despite successful revascularization in large-vessel occlusion strokes. Stroke 2014;45:1977-84.
31. Pexman JH, Barber PA, Hill MD, et al. Use of the Alberta Stroke Program Early CT Score (ASPECTS) for assessing CT scans in patients with acute stroke. AJNR Am J Neuroradiol 2001;22:1534-42.